Literature DB >> 28935027

Sex differences in the impact of acute stroke treatment in a population-based study: a sex-specific propensity score approach.

Lynda D Lisabeth1, Jonggyu Baek2, Lewis B Morgenstern3, Mathew J Reeves4, Devin L Brown5, Darin B Zahuranec5, Melinda A Smith5, Brisa N Sánchez2.   

Abstract

PURPOSE: We investigated whether sex modifies the association of acute stroke treatment on functional outcome using propensity score (PS) methods to minimize confounding and to explore the differential effects of confounders by sex.
METHODS: We included tissue plasminogen activator (tPA) treated (n = 84) and nontreated ischemic stroke cases (n = 143) from a population-based stroke study (2008-2013). The PS model that estimated the probability of receiving tPA included interactions between sex and treatment predictors. The outcome model included sex, tPA, and their interaction. In addition, sex-specific PS values were included as a continuous covariate and modeled using splines. We compared the results with conventional methods of statistical adjustment.
RESULTS: Conventional methods of adjustment suggested that women receive greater benefit from tPA than men. After taking into consideration that the influence of confounders, specifically age and stroke severity, differed by sex, we found no sex difference in the tPA-functional outcome association (P = .94).
CONCLUSIONS: Using PS methods that considered confounding of the sex × treatment interaction, we did not find that the association of tPA with functional outcome differed for women and men. Our findings may have implications for the methodologic approaches used to address confounding in studies that seek to compare stroke treatment effects by sex.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Sex factors; Stroke; Therapeutics

Mesh:

Substances:

Year:  2017        PMID: 28935027      PMCID: PMC5798880          DOI: 10.1016/j.annepidem.2017.07.006

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  17 in total

1.  Designing multi-ethnic stroke studies: the Brain Attack Surveillance in Corpus Christi (BASIC) project.

Authors:  Melinda A Smith; Jan M H Risser; Lemuel A Moyé; Nelda Garcia; Olubumi Akiwumi; Ken Uchino; Lewis B Morgenstern
Journal:  Ethn Dis       Date:  2004       Impact factor: 1.847

2.  Uric Acid Therapy Improves Clinical Outcome in Women With Acute Ischemic Stroke.

Authors:  Laura Llull; Carlos Laredo; Arturo Renú; Belén Pérez; Elisabet Vila; Víctor Obach; Xabier Urra; Anna Planas; Sergio Amaro; Ángel Chamorro
Journal:  Stroke       Date:  2015-07-09       Impact factor: 7.914

3.  A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation.

Authors:  A F Jorm
Journal:  Psychol Med       Date:  1994-02       Impact factor: 7.723

4.  Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals.

Authors:  S D Reed; S C Cramer; D K Blough; K Meyer; J G Jarvik
Journal:  Stroke       Date:  2001-08       Impact factor: 7.914

5.  Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials.

Authors:  David M Kent; Lori Lyn Price; Peter Ringleb; Michael D Hill; Harry P Selker
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

6.  Retrospective assessment of initial stroke severity with the NIH Stroke Scale.

Authors:  L S Williams; E Y Yilmaz; A M Lopez-Yunez
Journal:  Stroke       Date:  2000-04       Impact factor: 7.914

7.  Comparison of active and passive surveillance for cerebrovascular disease: The Brain Attack Surveillance in Corpus Christi (BASIC) Project.

Authors:  Paisith Piriyawat; Miriam Smajsová; Melinda A Smith; Sanjay Pallegar; Areej Al-Wabil; Nelda M Garcia; Jan M Risser; Lemuel A Moyé; Lewis B Morgenstern
Journal:  Am J Epidemiol       Date:  2002-12-01       Impact factor: 4.897

8.  Neurological, functional, and cognitive stroke outcomes in Mexican Americans.

Authors:  Lynda D Lisabeth; Brisa N Sánchez; Jonggyu Baek; Lesli E Skolarus; Melinda A Smith; Nelda Garcia; Devin L Brown; Lewis B Morgenstern
Journal:  Stroke       Date:  2014-03-13       Impact factor: 7.914

9.  The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

Authors:  Peter Sandercock; Joanna M Wardlaw; Richard I Lindley; Martin Dennis; Geoff Cohen; Gordon Murray; Karen Innes; Graham Venables; Anna Czlonkowska; Adam Kobayashi; Stefano Ricci; Veronica Murray; Eivind Berge; Karsten Bruins Slot; Graeme J Hankey; Manuel Correia; Andre Peeters; Karl Matz; Phillippe Lyrer; Gord Gubitz; Stephen J Phillips; Antonio Arauz
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321

10.  Three simple rules to ensure reasonably credible subgroup analyses.

Authors:  James F Burke; Jeremy B Sussman; David M Kent; Rodney A Hayward
Journal:  BMJ       Date:  2015-11-04
View more
  1 in total

1.  Calm the raging hormone - A new therapeutic strategy involving progesterone-signaling for hemorrhagic CCMs.

Authors:  Jun Zhang; Johnathan S Abou-Fadel
Journal:  Vessel Plus       Date:  2021-07-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.